Grace Cancer Foundation IPO: Latest Update
Grace Cancer Foundation launched its ₹1 crore fundraising issue through the Social Stock Exchange (SSE), with subscriptions scheduled from October 7 to October 9, 2026. The organisation is a Hyderabad-based charitable trust focused on cancer awareness, early detection, screening and treatment support for underserved communities.
Unlike a conventional equity IPO, this issue uses Zero Coupon Zero Principal (ZCZP) instruments. Investors contribute money to support the organisation's social initiatives rather than purchasing ordinary company shares for financial returns.
As of October 21, 2026, the published subscription window has ended. Investors should check the relevant exchange or official issue documents for the final status and any subsequent announcements.
Grace Cancer Foundation IPO Details
| Particular | Details |
|---|---|
| Organisation Name | Grace Cancer Foundation |
| Issue Type | Social Stock Exchange (SSE) |
| Instrument | Zero Coupon Zero Principal (ZCZP) |
| Issue Size | ₹1 crore |
| Issue Price | ₹10 per instrument |
| Opening Date | October 7, 2026 |
| Closing Date | October 9, 2026, as reported in issue announcements |
| Minimum Application | ₹1,000, as reported |
| Listing Exchange | NSE Social Stock Exchange |
| Grey Market Premium | Not available |
| Financial Returns | No interest or principal repayment |
| Purpose | Cancer awareness, screening and patient support |
Some IPO-tracking pages show a longer bidding window through October 21, while issue announcements and other exchange-data pages report October 9 as the closing date. Applicants should verify the final schedule using official exchange records.
Grace Cancer Foundation IPO GMP Today
There is no meaningful conventional grey market premium (GMP) for this issue. ZCZP instruments are designed to fund social causes and do not provide the usual equity-IPO return or principal repayment.
| Particular | Details |
|---|---|
| Issue Price | ₹10 |
| Latest GMP | Not available |
| Expected Listing Gain | Not applicable |
| Principal Repayment | No |
| Interest Payment | No |
Investors should not interpret the ₹10 issue price as a share price expected to rise after listing. The instrument represents a social contribution, not a conventional investment intended to generate capital gains.
About Grace Cancer Foundation
Grace Cancer Foundation, established in 2013, works to reduce the burden of cancer through preventive healthcare, community screening, awareness campaigns and assistance for patients who face financial barriers to treatment.
Its programmes include mobile cancer-screening units, medical camps, public education, patient navigation and research into technology-assisted early detection. The organisation works with communities and healthcare partners to improve access to cancer-related services.
Objectives of the Issue
The ₹1 crore fundraising issue is intended to support the foundation's social-impact activities. These include:
-
Expanding cancer awareness and prevention programmes.
-
Supporting early detection through screening camps and mobile units.
-
Helping underserved patients navigate referrals and treatment.
-
Improving access to information about cancer symptoms and risk factors.
-
Supporting research and technology initiatives related to early detection.
The precise allocation of funds and measurable targets should be checked in the issue's official offer document and impact reporting.
How Is an SSE ZCZP Issue Different from a Normal IPO?
A conventional equity IPO allows investors to purchase company shares and potentially earn returns through dividends or price appreciation. Grace Cancer Foundation's ZCZP issue follows a different model.
| Particular | Conventional Equity IPO | Grace Cancer Foundation ZCZP |
|---|---|---|
| Purpose | Raise capital for a business | Fund social-impact programmes |
| Instrument | Equity shares | ZCZP instruments |
| Interest | Depends on the instrument; equity has no fixed interest | No interest |
| Principal Repayment | Not guaranteed for equity | No principal repayment |
| Listing Gain | Possible, but not guaranteed | Not applicable |
| Main Objective | Investment and potential financial return | Social impact |
Although ZCZP instruments may be issued and held in dematerialised form, they are not ordinary tradable equity shares. Contributions should therefore be assessed as support for a social cause rather than as a source of investment returns.
Should You Apply for the Grace Cancer Foundation IPO?
This issue may interest people who want to support cancer awareness, screening and patient assistance through a regulated fundraising framework. However, it is not suitable for someone seeking conventional IPO listing gains or repayment of the invested amount.
Before contributing, review the official offer document, the organisation's planned use of funds, reporting commitments and the applicable tax treatment. Any tax deduction depends on the relevant eligibility conditions and documentation.
Disclaimer: This article is for informational and educational purposes only. ZCZP instruments do not offer financial returns or principal repayment. Verify the official issue documents and applicable rules before making a contribution.
Loading comments...